[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100536601":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":33,"responsibleParty":47,"collaborators":10,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":64,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"University Medical Center Groningen","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients",null,"Participants will undergo a visual acuity test. Next they will perform the SONDA test 2 times at one visit and once more in a later visit Participants will fill in a questionnaire",[13],"Diagnostic Test: SONDA",{"label":15,"type":10,"description":16,"interventionNames":17},"Healthy controls","Participants will perform the SONDA test 2 times",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","SONDA","Perimetry based visualfield analysis",[15,9],[25],{"name":26,"affiliation":5,"role":27},"Jos MA Kuijlen, MD\u002FPHD","PRINCIPAL_INVESTIGATOR",[29],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","050 361 2837","jmakuijlen@umcg.nl",[34],{"facility":35,"status":10,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":10},"UMCG","Groningen","Provincie Groningen","9713 GZ","Netherlands","NL",{"type":42,"coordinates":43},"Point",[44,45],6.56667,53.21917,{"lat":45,"lon":44},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100536601",false,"NCT06266949","Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors","Inclusion Criteria:\n\n* Diagnosed with a (supra)sellar tumor\n* Visual field loss based on the most recent SAP; False positive rate \\\u003C15%; fixation losses \\\u003C20%\n* Informed written consent\n\nExclusion Criteria:\n\n* Neurological disorders\n* Eye disease not related to a (supra)sellar tumor","ALL","18 Years",{"count":57,"type":58},30,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.",[62,63],"Pituitary Tumor","Visual Fields Hemianopsia","NOT_YET_RECRUITING","2025-05-01",{"date":67,"type":68},"2025-05-02","ACTUAL",{"date":70,"type":58},"2025-08-01",{"date":72,"type":58},"2026-08-01",{"name":5,"class":6},1]